GAMCO Investors’s Epizyme, Inc EPZM Stock Holding History

GAMCO Investors’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$15K	–	942
2022 Q2	$15K	Buy	+10,000	New	+$7.35K	﹤0.01%	897

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

GAMCO Investors's EPZM Position: Q3 2022 in Review

GAMCO Investors sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 10,000 shares — an estimated $15K sold.

GAMCO Investors first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $15K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

GAMCO Investors reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
GAMCO Investors sold 10,000 Epizyme, Inc shares in Q3 2022, an estimated $15K.
GAMCO Investors first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
GAMCO Investors's Epizyme, Inc position peaked at $15K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on GAMCO Investors's 13F filing for Q3 2022, filed 10 Nov 2022.